Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
---|
02/23/2011 | CN101981036A Pyrrolo [2, 3-D] pyridines and use thereof as tyrosine kinase inhibitors |
02/23/2011 | CN101981035A Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments |
02/23/2011 | CN101981034A Triazolopyridazines as PAR1 inhibitors, production thereof, and use as medicaments |
02/23/2011 | CN101981033A Substituted imidazopyridazines useful as kinase inhibitors |
02/23/2011 | CN101981032A Substituted arylamide diazepinopyrimidone derivatives for the treatment of neurodegenerative diseases caused by abnormal activity of GSK3-beta |
02/23/2011 | CN101981031A Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them |
02/23/2011 | CN101981030A Dihydro- 1H- pyrrolo [1,2-a] indol-1-yl carboxylic derivatives which act as S1P1 agonists |
02/23/2011 | CN101981025A Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor |
02/23/2011 | CN101980711A Aromatic heterocyclic fused indolobenzadiazepine HCV NS5B inhibitors |
02/23/2011 | CN101302218B Preparation of Trandolapril diketone |
02/22/2011 | US7893280 2,4-disubstituted thiazolyl derivatives |
02/22/2011 | US7893277 Poly(ethylene glycol) containing chemically disparate endgroups |
02/22/2011 | US7893085 3-(4-Bromo-2-fluoro-phenylamino)-thieno[3,2-c]pyridine-2-carboxylic acid (2,2-dimethyl-[1,3]dioxolan-4-ylmethoxy)-amide; mitogen activated protein extracellular kinase kinase (MEK) inhibitor; antiproliferative, antiinflammatory agent |
02/22/2011 | US7893068 Physiologically active substances |
02/22/2011 | US7893058 Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases |
02/22/2011 | US7893051 Thiophenyl and pyrrolyl azepines as serotonin 5-HT2c receptor ligands and uses thereof |
02/22/2011 | CA2553879C Viral polymerase inhibitors |
02/22/2011 | CA2485909C Azepinoindole and pyridoindole derivatives as pharmaceutical agents |
02/22/2011 | CA2474823C Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives |
02/17/2011 | WO2011019986A2 Processes for preparing pemetrexed |
02/17/2011 | WO2011019405A1 Pyrimidine compounds as tuberculosis inhibitors |
02/17/2011 | WO2011018994A1 Phthalocyanine compound, preparation method therefor, and coloring composition including said phthalocyanine compound |
02/17/2011 | WO2011018894A1 Pyrrolopyrimidine derivatives as potassium channel modulators |
02/17/2011 | WO2011018495A1 New compounds for the treatment of cns disorders |
02/17/2011 | WO2011018494A1 Crystalline compound of 7-[(3r)-3-amino-1-oxo-4-(2, 4, 5-trifluorphenyl)butyl]-5, 6, 7, 8-tetrahydro-3-(tri fluormethyl)-1, 2, 4 -triazolo[4,3-a]pyrazine |
02/17/2011 | WO2011018454A1 Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation |
02/17/2011 | US20110040088 Fused heterocyclic compounds |
02/17/2011 | US20110040087 Peptide turn mimetics |
02/17/2011 | US20110039856 Polymorphs of a c-met/hgfr inhibitor |
02/17/2011 | US20110039838 Pyrrolotriazine compounds as kinase inhibitors |
02/17/2011 | US20110039836 Tricyclic antibiotics |
02/17/2011 | US20110039835 Substituted arylamide diazepinopyrimidone derivatives |
02/17/2011 | US20110039831 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives |
02/17/2011 | US20110039825 Ligands of alpha-adrenoceptors, dopamine, histamine, imidazoline and serotonin receptors and their use |
02/17/2011 | US20110039824 1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate nuclear receptor inhibitors |
02/17/2011 | US20110038876 Heterocyclic compounds and use thereof as erk inhibitors |
02/17/2011 | US20110038835 Anilides and analogs as rho kinase inhibitors |
02/17/2011 | CA2771011A1 Crystalline compound of 7-[(3r)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine |
02/17/2011 | CA2770873A1 Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation |
02/16/2011 | EP2284920A1 Compound for organic electric field light-emitting element and organic electric field light-emitting element |
02/16/2011 | EP2284172A1 Immunomodulating heterocyclic compounds |
02/16/2011 | EP2284171A1 Amides of diazabicycloalkanes selective for nicotinic acetylcholine receptor sub-types |
02/16/2011 | EP2283021A2 Switchable special effect substances |
02/16/2011 | EP2283020A1 Substituted imidazopyr-and imidazotri-azines |
02/16/2011 | EP2283019A1 Gpr119 receptor agonists |
02/16/2011 | EP2283018A1 Hepatitis c virus inhibitors |
02/16/2011 | EP2283017A1 Fused pyrimidineone compounds as trpv3 modulators |
02/16/2011 | EP2283016A1 Thiophenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as bace-1 inhibitors, compositions, and their use |
02/16/2011 | EP2283004A1 Amido-thiophene compounds and their use |
02/16/2011 | EP1723151B1 Pyrrolobenzodiazepines as key intermediates in the synthesis of dimeric cytotoxic pyrrolobenzodiazepines |
02/16/2011 | CN101977915A Macrocyclic serine protease inhibitors |
02/16/2011 | CN101977914A Compounds for the treatment of hepatitis c |
02/16/2011 | CN101977913A Pyrrolo[2,3-d]pyrimidin-2-yl-amine derivatives as pkc-theta inhibitors |
02/16/2011 | CN101977912A Mtor inhibitor salt forms |
02/16/2011 | CN101977655A Indazole derivatives |
02/16/2011 | CN101974030A Preparation method of ammonium glyphosate technical product |
02/16/2011 | CN101974000A Method for separating four isomers of tetra(o-aminophenyl)porphyrin |
02/16/2011 | CN101973999A Trimethoxysulfydrylporphyrin with carbon chain length being 6 |
02/16/2011 | CN101973998A Pyrrolopyrimidine A2b selective antagonist compounds, their synthesis and use |
02/16/2011 | CN101973997A Method for preparing sitagliptin phosphate side chain |
02/16/2011 | CN101973996A Imide biotin intermediate monoester and preparation method and use thereof |
02/16/2011 | CN101972675A Cobalt sulfonated phthalocyanine desulfurization catalyst and preparation method thereof |
02/16/2011 | CN101262041B Application of dissoluble tetraalkylammonium axial phthalocyanine compound replacement in making organic film transistor |
02/15/2011 | US7888505 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one carboxylic acids, their esters, and methods of synthesis thereof |
02/15/2011 | US7888502 Titanyl phthalocyanine processes and photoconductors thereof |
02/15/2011 | US7888501 Process for making organic photosensitive pigment |
02/15/2011 | US7888371 Use of triazolopyrimidine derivatives as microbicides |
02/15/2011 | US7888359 Cyclohexyl or piperidinyl carboxamide antibiotic derivatives |
02/15/2011 | US7888357 Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death |
02/15/2011 | US7888356 Antibiotics containing borinic acid complexes and methods of use |
02/15/2011 | US7888349 Piperazine, [1,4]Diazepane, [1,4]Diazocane, and [1,5]Diazocane fused imidazo ring compounds |
02/15/2011 | US7888347 Pyrazolo [3,4-D]azepine derivatives as histamine H3 antagonists |
02/15/2011 | US7888343 Substituted, bicyclic 8-pyrrolidinoxanthines, and methods for their use as inhibitors of dipeptidyl peptidase |
02/15/2011 | US7888285 2,4,6-phenyl substituted cyclic ketoenols |
02/15/2011 | CA2558272C Pyridone derivative |
02/15/2011 | CA2496842C Heterocyclic aromatic compounds useful as growth hormone secretagogues |
02/15/2011 | CA2481460C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics |
02/15/2011 | CA2470067C Imidazoquinoline derivatives |
02/15/2011 | CA2325937C Peptide turn mimetics |
02/10/2011 | WO2011017342A2 Mesoionic pesticides |
02/10/2011 | WO2011017334A2 Mesoionic pesticides |
02/10/2011 | WO2011017299A2 PROCESS FOR PREPARING A 2-ALKYNYL SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE |
02/10/2011 | WO2011017108A2 Cyclopropyl modulators of p2y12 receptor |
02/10/2011 | WO2011017009A1 Novel azaheterocyclic compounds |
02/10/2011 | WO2011016648A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
02/10/2011 | WO2011016576A1 Alanine derivatives as inhibitors of apoptosis proteins |
02/10/2011 | WO2011016016A1 Processes for the preparation of vardenafil |
02/10/2011 | WO2011015652A1 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives as c-met tyrosine kinase modulators |
02/10/2011 | WO2011015343A1 Metabotropic glutamate receptor modulators |
02/10/2011 | WO2010068810A3 Certain substituted amides, method of making, and method of use thereof |
02/10/2011 | US20110034475 1-aza-bicyclo[3.3.1]nonanes |
02/10/2011 | US20110034473 Novel (pyrroloquinoxalinyl) pyrazinecarbohydrazide-oxalic acid co-crystal for treatment of cancer and other diseases |
02/10/2011 | US20110034472 Novel Compounds for Treatment of Cancer and Disorders Associated With Angiogenesis Function |
02/10/2011 | US20110034468 Triazolo compounds useful as dgat1 inhibitors |
02/10/2011 | US20110034467 Dihydro-pyrrolopyridine-, dihydro-pyrrolopyridazine- and dihydro-pyrrolopyrimidine-derivatives and use thereof |
02/10/2011 | US20110034456 Imidazopyridazines as par1 inhibitors, production thereof, and use as medicaments |
02/10/2011 | US20110034452 Triazolium salts as par1 inhibitors, production thereof, and use as medicaments |
02/10/2011 | US20110034451 Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments |
02/10/2011 | US20110034440 Homocysteine synthase inhibitor |
02/10/2011 | US20110034438 Structural mimetics of proline-rich peptides and the pharmaceutical use thereof |